Following David Slade’s transition from his role as Global Director of Pharmacy and Compounding last year, Russell has guided the division as Acting CEO with a clear focus on strategic alignment, patient-centred care and operational excellence. His leadership has been instrumental in driving sustainable growth and innovation across an increasingly complex healthcare landscape.
Russell Hill appointed Chief Executive Officer (CEO) of Slade Pharmacy & Slade Health
We’re pleased to share the formal appointment of Russell Hill as Chief Executive Officer of Pharmacy and Compounding across Australia and New Zealand, leading Slade Pharmacy and Slade Health.
Throughout his time in the role, Russell has worked closely with his team to integrate digital transformation initiatives, enhance commercial excellence, and ensure the delivery of high-quality, patient-first services. His appointment marks an important milestone in the continued evolution of Slade Health and Slade Pharmacy’s capabilities within Icon Group.
“Russell’s appointment is a testament to his unwavering commitment to our mission and the impact of his leadership across both pharmacy and compounding,” said Icon Group CEO Mark Middleton.
“His strategic vision, collaborative spirit and deep understanding of our business will continue to shape the future of these critical services. I’m thrilled to see him step into this role and lead our teams into the next phase of growth.”
This announcement comes at a special moment in our history, as we celebrate 60 years of Slade – a legacy built on innovation, integrity and a deep commitment to patient care.
“Slade has a proud 60-year history of delivering trusted, high-quality care to patients and communities,” said Russell Hill.
“It’s incredibly humbling to step into this role knowing the remarkable history that has shaped our pharmacy and compounding services, and the leaders and teams who have built its success. I’m proud to contribute to Slade’s legacy, working together to bring more care, to more people, closer to home.”
